Skip to main content
. 2022 Jan 31;603(7901):493–496. doi: 10.1038/s41586-022-04465-y

Extended Data Fig. 1. Nucleocapsid antibody responses.

Extended Data Fig. 1

Nucleocapsid antibody responses at month 8 following final vaccination with Ad26.COV2.S (N = 20) or BNT162b2 (N = 27) by meso-scale discovery (MSD) electrochemoluminscent assay. SARS-CoV-2 convalescent and pre-pandemic samples were included as positive and negative controls, respectively. Relative light units are shown.